OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert LONN.../  DE000ME7GVA7  /

Stuttgart
6/4/2024  4:20:15 PM Chg.+1.91 Bid10:00:34 PM Ask10:00:34 PM Underlying Strike price Expiration date Option type
257.02EUR +0.75% -
Bid Size: -		 -
Ask Size: -		 LONZA N - CHF 9/27/2024 Call
GlobeNewswire 5/30 Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire 5/15 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire 5/8 Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 Maravai LifeSciences Reports First Quarter 2024 Financial Results
GlobeNewswire 4/4 Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire 4/4 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 2/27 Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 2/15 Galapagos presents at EBMT-EHA annual meeting 2024
GlobeNewswire 1/4 Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire 12/19/2023 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire 12/9/2023 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire 12/7/2023 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire 12/7/2023 Business Update
GlobeNewswire 11/6/2023 Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 11/1/2023 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 10/19/2023 Viralgen welcomes back Andy Holt as CCO
GlobeNewswire 10/16/2023 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 10/2/2023 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 9/20/2023 Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
GlobeNewswire 9/19/2023 Galapagos appoints Simon Sturge to its Board of Directors
GlobeNewswire 9/13/2023 Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer
GlobeNewswire 9/7/2023 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire 9/5/2023 Ascendis Pharma Reports Second Quarter 2023 Financial Results
GlobeNewswire 3/14/2022  aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
GlobeNewswire 2/10/2022 Finch Therapeutics Announces Additions to Senior Leadership Team